Crohn’s disease has no single cause. It develops when a combination of genetic susceptibility, immune system malfunction, gut bacteria imbalances, and environmental triggers converge to create chronic inflammation in the digestive tract. Globally, about 4.5 people per 100,000 are diagnosed each year, and that number has been climbing, particularly in rapidly urbanizing countries.
Genetics Set the Stage
More than 200 genetic regions have been linked to Crohn’s, but a handful play outsized roles. The most well-studied is a gene called NOD2, which acts as an intracellular sensor for bacteria. NOD2 helps the immune system recognize bacterial fragments and respond appropriately. When this gene is mutated, it can alter the function of specialized cells in the gut lining that produce antimicrobial compounds, leading to lesions in the small intestine.
Another key gene, ATG16L1, is involved in autophagy, the process your cells use to break down and recycle invaders like bacteria and damaged proteins. ATG16L1 mutations have been specifically linked to Crohn’s affecting the ileum, the last section of the small intestine. A third gene, the IL-23 receptor, influences how aggressively certain immune cells drive inflammation. When overactive, this receptor ramps up a chain of signaling that keeps inflammation going long after it should have stopped.
Having one or more of these genetic variants doesn’t guarantee you’ll develop Crohn’s. Most people who carry them never do. But these genes create vulnerability, making the immune system more likely to overreact to triggers that a genetically typical gut would handle without trouble.
An Immune System That Won’t Stand Down
In a healthy gut, the immune system tolerates trillions of bacteria living in the intestine while still defending against genuine threats. In Crohn’s, that tolerance breaks down. The immune system treats normal gut bacteria as invaders and launches an inflammatory response it can’t shut off.
A protein called tumor necrosis factor, or TNF, is central to this process. TNF is a signaling molecule that recruits immune cells to sites of infection, triggers the production of other inflammatory compounds, and promotes the formation of granulomas, the small clusters of immune cells that are a hallmark of Crohn’s. In a healthy person, TNF activity resolves once the threat is gone. In Crohn’s, TNF keeps recruiting white blood cells and driving inflammation in the intestinal wall, causing the swelling, ulceration, and tissue damage that define the disease.
Two types of immune cells are especially active. Th1 cells flood the gut lining and produce large amounts of a compound called interferon-gamma, which sustains inflammation. Th17 cells, activated through the IL-23 signaling pathway, produce yet another inflammatory compound that further damages the intestinal wall. This layered immune response is why Crohn’s is chronic and relapsing: multiple overlapping pathways keep the inflammation cycle turning.
Gut Bacteria Are Out of Balance
People with Crohn’s consistently show a different mix of gut bacteria compared to people without the disease. Certain potentially harmful species, including strains of E. coli and a bacterium called Serratia marcescens, are found in higher numbers. These bacteria often co-exist with the fungal organism Candida tropicalis, forming a kind of microbial partnership that promotes inflammation.
At the same time, beneficial bacterial species that produce anti-inflammatory compounds are depleted. This imbalance, called dysbiosis, weakens the protective mucus layer that normally separates gut bacteria from the intestinal wall. When that barrier thins, bacteria come into direct contact with immune cells in the gut lining, triggering the kind of overreaction described above. Whether this dysbiosis is a cause or a consequence of Crohn’s (or both) remains an open question, but it clearly plays a role in sustaining the disease once it begins.
Environmental Triggers That Raise Risk
Genes and immune dysfunction alone don’t explain why Crohn’s rates have surged in the past few decades, far too quickly for genetic changes to account for. Environmental factors are filling that gap.
Smoking
Smoking roughly doubles the risk of developing Crohn’s, with no clear dose-dependent pattern, meaning even light smokers face elevated risk. Interestingly, smoking has the opposite effect on ulcerative colitis, the other major form of inflammatory bowel disease, where it appears somewhat protective. The reasons for this split aren’t fully understood, but Crohn’s is one of the few autoimmune-related conditions where smoking is a confirmed, independent risk factor.
Ultra-Processed Foods and Emulsifiers
The Western diet is increasingly under scrutiny. Experimental studies have shown that common food additives, particularly synthetic emulsifiers like carboxymethylcellulose and polysorbate-80, can disrupt the intestinal mucus barrier and shift the gut microbiome toward a more inflammatory profile. In animal models, these additives directly caused colitis. Another additive, carrageenan (a thickener derived from seaweed), has been linked to depletion of anti-inflammatory gut bacteria.
Prospective research in humans has found stronger associations between certain ultra-processed food categories and Crohn’s risk, particularly packaged breads, sweet snacks, desserts, sauces, and spreads. These are among the foods richest in emulsifying and thickening agents. Small pilot studies have also shown that restricting emulsifiers in the diet improved Crohn’s-related symptoms, though larger trials are still needed.
Urbanization
Crohn’s has historically been far more common in North America and Western Europe, but rates are now climbing sharply in Asia, South America, and Africa as those regions urbanize. Data from China illustrates this clearly: among over 3,400 inflammatory bowel disease cases tracked between 1998 and 2013, roughly 82% of patients lived in cities rather than rural areas. Rising Crohn’s incidence tracked almost perfectly with increasing urban population over a 14-year period.
Urban living changes gut bacteria. Studies comparing urban and rural populations in China found significant differences in microbial composition, with urban residents’ microbiomes shifting to resemble those of Americans. This altered bacterial profile may be one mechanism through which city living increases Crohn’s risk, alongside changes in diet, air quality, and reduced exposure to diverse environmental microbes.
The Hygiene Hypothesis
One influential theory holds that growing up in overly clean environments prevents the immune system from learning to tolerate harmless microbes, leaving it prone to attacking the body’s own tissues later. A study comparing childhood environmental exposures between Crohn’s patients and healthy controls found that people who later developed Crohn’s had exposure scores roughly 30 to 40 percent lower during childhood, meaning less contact with farm animals, soil, unpasteurized foods, and other microbial sources across all age groups from birth through age 18.
This tracks with the urbanization data and with the observation that Crohn’s is most common in the most industrialized nations. The immune system, particularly the gut-associated immune system, appears to need early microbial “training” to function properly. Without it, the risk of misdirected immune responses rises.
The Bacterial Infection Theory
For decades, researchers have debated whether a specific bacterium called Mycobacterium avium subspecies paratuberculosis (MAP) might cause Crohn’s. MAP causes Johne’s disease, a chronic intestinal inflammation in cattle that looks remarkably similar to Crohn’s. MAP has been detected more frequently in the tissues and blood of Crohn’s patients than in healthy individuals, and it survives commercial pasteurization, meaning it can persist in the food supply.
However, the evidence against MAP as a primary cause is substantial. People who work closely with MAP-infected animals don’t develop Crohn’s at higher rates. MAP has been found in people without Crohn’s. Most tellingly, a two-year randomized trial of antibiotics specifically targeting MAP failed to produce lasting benefit beyond an initial 16-week response. And Crohn’s responds well to immunosuppressive drugs, treatments that would typically worsen a true mycobacterial infection. The current consensus is that MAP is, at most, one of many microbial factors rather than the cause.
Why It All Comes Together Differently in Each Person
Crohn’s is best understood as a threshold disease. Genetic variants lower the threshold. Environmental exposures push someone closer to it. An altered microbiome may tip someone over. The specific combination varies from person to person, which is why Crohn’s can appear anywhere in the digestive tract, at almost any age, and with vastly different severity. Incidence rises after age 14, and the highest rates are in the 60 to 64 age group, though diagnosis in the teens and twenties remains common. Men are slightly more affected in older age groups.
This also explains why no single intervention prevents Crohn’s. You can’t change your genes, but the modifiable risk factors, including smoking, highly processed diets, and possibly early microbial exposure, represent areas where the accumulating evidence points toward real influence on who develops this disease and who doesn’t.